64 results
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
6 Jun 24
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
8:00am
this offering for working capital and general corporate purposes. This offering is expected to close on or about June 5, 2024, subject to satisfaction
424B3
NDRA
ENDRA Life Sciences Inc
5 Jun 24
Prospectus supplement
8:20am
June 5, 2024, subject to satisfaction of certain customary closing conditions.
Craig-Hallum
The date of this prospectus is June 4, 2024.
iii
Page … , subject to satisfaction of certain customary closing conditions.
We have agreed to pay the Placement Agent an aggregate fee equal to 7.0% of the gross
424B5
rmkrhvnf7s60
3 Apr 24
Prospectus supplement for primary offering
5:14pm